UK markets open in 5 hours 35 minutes
  • NIKKEI 225

    28,137.22
    -38.65 (-0.14%)
     
  • HANG SENG

    20,201.94
    0.00 (0.00%)
     
  • CRUDE OIL

    88.47
    -0.54 (-0.61%)
     
  • GOLD FUTURES

    1,790.00
    -1.20 (-0.07%)
     
  • DOW

    32,803.47
    +76.67 (+0.23%)
     
  • BTC-GBP

    19,242.56
    +167.52 (+0.88%)
     
  • CMC Crypto 200

    540.31
    +5.08 (+0.95%)
     
  • ^IXIC

    12,657.55
    -63.04 (-0.50%)
     
  • ^FTAS

    4,111.51
    -6.81 (-0.17%)
     

Philip Morris International Inc. Declares Regular Quarterly Dividend of $1.25 Per Share

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, December 09, 2021--(BUSINESS WIRE)--Regulatory News:

The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.25 per common share, payable on January 10, 2022, to shareholders of record as of December 23, 2021. The ex-dividend date is December 22, 2021. For more details on stock, dividends and other information, see www.pmi.com/dividend.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, versions of PMI's IQOS Platform 1 device and consumables have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn products, nicotine-containing vapor products and oral nicotine products. As of September 30, 2021, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 14.9 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005600/en/

Contacts

Philip Morris International
Investor Relations:
New York: +1 (917) 663 2233
Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com

Media:
Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting